Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Docking Simulations and Virtual Screening to find Novel Ligands for T۳S in Yersinia pseudotuberculosis YPIII, A drug target for type III secretion (T۳S) in the Gram-negative pathogen Yersinia pseudotuberculosis

مقالات مروری و پژوهشی شیمی، دوره: 4، شماره: 3
Year: 1400
COI: JR_CHRL-4-3_001
Language: EnglishView: 47
This Paper With 15 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 15 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Emmanuel Edache - Department of Pure and Applied Chemistry, University of Maiduguri, Brono State, Nigeria
Uzairu Adamu - Chemistry, Physical, Ahamdu Bello University, Zaria, Nigeria
Paul Mamza - Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.
Shallangwa Gideon - Chemistry, Physical sciences, ABU, Zaria, Nigeria.

Abstract:

In the Gram-negative pathogen Yersinia pseudotuberculosis and Chlamydia, the aggregate use of molecular docking, molecular dynamic simulations, and ADMET was successfully used to develop salicylidene acyl hydrazides as type III secretion (T۳S) inhibitors. The molecular docking analysis was carried out on CMP's simulated protein, which helped to correlate amino acid associations with the ligand. The review of molecular dynamics simulations showed that the CMP protein A-chain was stable at and above ۱۰۰ps concerning temperature, total energy, and kinetic energy. Virtual screening was performed to distinguish the new inhibitors depending on pharmacophore modeling and molecular docking. Based on the Rerank score fitness feature, ten top-ranked compounds were discovered. In keeping with the reference ranges, ADME tests were carried out on compounds retrieved from simulated sampling. For our further drug design, all the findings will give us more useful evidence.

Keywords:

Paper COI Code

This Paper COI Code is JR_CHRL-4-3_001. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1259922/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Edache, Emmanuel and Adamu, Uzairu and Mamza, Paul and Gideon, Shallangwa,1400,Docking Simulations and Virtual Screening to find Novel Ligands for T۳S in Yersinia pseudotuberculosis YPIII, A drug target for type III secretion (T۳S) in the Gram-negative pathogen Yersinia pseudotuberculosis,https://civilica.com/doc/1259922

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support